Delivery Order SPE2DB25D7068-SPE2DB25FTYDZ
- Not listed
- The Defense Logistics Agency awarded a $1,763.79 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This contract, valued at $2,396.05, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion on July 15, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is...
- The Defense Logistics Agency awarded a $13,399.76 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,146.68 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,747.17 and is scheduled for completion by June 23, 2025. The contract does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $12,716.88 and an ultimate completion date of August 7, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $4,539.09 and a completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a $10,330.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $2,133.73. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for ultimate completion on September 5, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. Ondansetron is an...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25K to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on June 5, 2025, with completion expected by June 6, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement from the vendor's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYDZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This contract, valued at $6,284.52, is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an anti-nausea medication commonly used in military and federal healthcare settings to manage chemotherapy-induced nausea, post-operative nausea, and radiation therapy side effects. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. As one of the Defense Logistics Agency's primary pharmaceutical vendors, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitive and flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 9/26/25 |